Cytiva’s 2025 Global Biopharma Index shows widening gaps across regions as talent shortages, regulatory strain, and uneven sustainability progress weigh on growth.
The New Jersey investment more than doubles Hovione’s U.S. spray drying capacity to support solubility enhancement and bioavailability in drug development.
The investment reportedly enhances solid-phase peptide synthesis and purification capacity to strengthen domestic production of active pharmaceutical ingredients.
